ASCIA Education Projects

Anaphylaxis | Food Allergy | Respiratory/Insect Allergy  | Drug Allergy | Skin/Allergy | Immunodeficiency | Testing | COVID-19   

The ASCIA team works with ASCIA committees and working parties to review, update and develop accessible, consistent and evidence based resources, education and training, to support ASCIA members, other health professionals, patients, carers and the community. 

The resources listed below have been developed and/or updated since July 2021.

 ASCIA Anaphylaxis Resources 

Action Plans, Forms and Checklists

• ASCIA Action Plan FAQ Updated April 2022
• ASCIA Action Plans (5 versions) and First Aid Plans (3 versions) Updated June/December 2021
• ASCIA First Aid Plan for Anaphylaxis - Pictorial New August 2021
• Anaphylaxis Checklist for Adrenaline Prescribers Updated September 2021
• Anaphylaxis Checklist for Pharmacists Updated September 2021
• Anaphylaxis Checklist for Patients Updated September 2021
• Anaphylaxis Checklist for Transitioning from Paediatric to Adult Care Updated September  2021 
• Anaphylaxis Checklist for Travelling with Allergy, Asthma or Anaphylaxis Updated September 2021

• Adrenaline Injectors Fast Facts New March 2022
• Adrenaline Injectors FAQ Updated January 2022
• Adrenaline Injector Instructions - How to give EpiPen Updated July 2021 
• Adrenaline Injector Instructions - How to give Anapen Updated July 2021
• Adrenaline Injectors for General Use Updated September 2021
• Adrenaline Injector Supply Updates Updated September 2021
• Adrenaline Injector Storage, Expiry, Disposal Updated September 2021

• Idiopathic Anaphylaxis New April 2022
• Adrenaline for Treatment of Anaphylaxis Patient Information Updated September 2021
• Anaphylaxis Patient Information - English Updated September 2021

Guidelines for Health Professionals 

• ASCIA Guidelines - Acute Management of Anaphylaxis Updated July 2021
• ASCIA Guidelines - Adrenaline (Epinephrine) Autoinjector Prescription Updated March 2022
• ASCIA Guidelines Summary - Adrenaline (Epinephrine) Injector Prescription New March 2022 

ASCIA Anaphylaxis e-Training Courses

• ASCIA Anaphylaxis e-training - Health Professionals Updated September 2021
• ASCIA Anaphylaxis refresher e-training for health professionals New February 2022
• ASCIA Anaphylaxis e-training for pharmacists Updated September 2021
• ASCIA Anaphylaxis refresher e-training for pharmacists New February 2022
• ASCIA Anaphylaxis refresher e-training New July 2021 
• ASCIA Anaphylaxis e-training - Schools and Childrens Education/Care (6 versions) Updated September 2021 
• ASCIA Anaphylaxis e-training - Community Updated September 2021

ASCIA Food Allergy Resources 

Information for Patients, Consumers and Carers - Food Allergy

• Food Allergen Challenges Consent Form New March 2022

Information for Patients, Consumers and Carers - Other Adverse Reactions to Foods

• Oral Allergy Syndrome FAQ New September 2021
• Sulfite Sensitivity FAQ Updated July 2021
• Eosinophilic Oesophagitis (EoE) FAQ New July 2021
• Eosinophilic Oesophagitis (EoE) Dietary Guide - 2FED New July 2021
• Eosinophilic Oesophagitis (EoE) Dietary Guide - 4FED New July 2021

Action and Management Plans

• Eosinophilic Oesophagitis (EoE) Action Plan New July 2021
• Eosinophilic Oesophagitis (EoE) Management Plan New July 2021

Information for Health Professionals

• ASCIA Position Paper - Food Allergen Challenges New March 2022
• ASCIA Consent Form - Food Allergen Challenges New March 2022
• ASCIA Guide - Milk Substitutes in Cow’s Milk (Dairy) Allergy Updated March 2022
• ASCIA Food Allergy e-training for health professionals Updated November 2021
  
• ASCIA Food Allergy e-training for pharmacists Updated November 2021

 ASCIA Respiratory and Insect Allergy Resources 

• ASCIA Allergic Rhinits e-training - Health Professionals Updated March 2022
• ASCIA Allergen Immunotherapy e-training - Health Professionals Updated May 2022
• ASCIA Position Paper - Chronic Rhinosinusitis with Nasal Polyps New November 2021
• ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT) Updated May 2021
• ASCIA Treatment Plan - Sublingual Immunotherapy (SLIT) New June 2021
• How to Safely Remove Ticks animation New  June 2021

The following project is scheduled to be completed in 2022:

• Updated ASCIA Allergic Rhinitis Clinical Update for health professionals

ASCIA Drug (Medication) Allergy Resources 

• ASCIA Antibiotic Allergy Challenges FAQ New March 2022
• ASCIA Antibiotic Allergy Challenges Consent Form New March 2022 
• ASCIA Action Plan for Drug (Medication) Allergy Updated June 2021
• ASCIA Record for Drug (Medication) Allergy Updated June 2021
• ASCIA Consensus Statement - Cephalosporin Allergy (available to Members only) New July 2021 

ASCIA Skin/Allergy Resources 

• Chronic Spontaneous Urticaria (CSU) FAQ New February 2022 
• Eczema (Atopic Dermatitis) FAQ Updated March 2022
• ASCIA Action Plan for Eczema Updated March 2022
• ASCIA Stepwise Management Plan for Eczema Updated March 2022

The following project is scheduled to be completed in 2022:

• New ASCIA Atopic Dermatitis (Eczema) Clinical Update for health professionals 

ASCIA Immunodeficiency Resources 

Information for Patients, Consumers and Carers

• Common Variable Immunodeficiency (CVID) Updated October 2021
• COVID-19 and Immunodeficiency FAQ Updated October 2021
• Hereditary Angioedema (HAE) FAQ New October 2021
• Immunoglobulin Replacement Therapy (IRT) Updated October 2021
• Primary Immunodeficiency (Inborn Errors of Immunity) Updated October 2021
• Severe Combined Immunodeficiency (SCID) Updated October 2021
• Subcutaneous Immunoglobulin (SCIg) Therapy - General Information Updated August 2021

Information for Health Professionals

• ASCIA Immunoglobulin Replacement Therapy e-training New March 2022
• ASCIA Position Paper and Management Plan - Hereditary Angioedema (HAE) Updated January 2022
• ASCIA Position Statement - Immunoglobulin Replacement Therapy (IRT) in PID/IEI New September 2021

The following projects are scheduled to be completed in 2022:

• New ASCIA Hereditary Angioedema (HAE) e-training for health professionals 
• Updated ASCIA PID/IEI e-training for health professionals 
• New ASCIA immune system and immunodeficiency animations

ASCIA Testing Resources 

The following projects are scheduled to be completed in 2022: 

• Mastocytosis and other mast cell disorders FAQ
• Food allergy testing FAQ

ASCIA COVID-19 Resources  

Information for Patients, Consumers and Carers 

• Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Frequently Asked Questions (FAQ) for patients, consumers and carers Updated January 2022
• COVID-19 and Immunodeficiency Updated October 2021
• Checklist - Actions to Reduce the Spread of COVID-19 Updated October 2021

Information for Health Professionals  

• COVID-19 Vaccination Guidelines for Clinical Immunology/Allergy Specialists Updated September 2021
• Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Position Statement for health professionals Updated September 2021
• Allergy and COVID-19 Vaccination - Guide for health professionals Updated September 2021
• Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Guide for health professionals Updated September 2021  

Improving Access to ASCIA information

ReadSpeaker is available on the ASCIA webpages (html, not pdfs) for patients, consumers and carers, to improve access for people with:

• Vision impairment, limited reading ability or learning disabilities, by allowing text to speech (TTS).
• Non-English speaking backgrounds - information can be translated into 20 different languages by highlighting the text and selecting 'translate’.

Content updated June 2022